Outlook Therapeutics is trading at $0.59, with a -5.37% change; no clear company or sector catalyst was identified. - Search results showed no September 30 company announcement explaining the decline; the latest listed company press release was September 11. - Major U.S. indices were broadly higher, so the decline does not appear to track the overall market.